Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Kwality Pharmaceuticals Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 69 | 67 | 70 | 78 | 92 | 80 | 90 | 84 | 116 | 111 | 111 | 123 | 157 |
| Expenses + | 57 | 54 | 54 | 61 | 71 | 63 | 70 | 67 | 90 | 87 | 86 | 93 | 118 |
| Operating Profit | 11 | 14 | 15 | 17 | 21 | 17 | 20 | 18 | 26 | 24 | 25 | 30 | 39 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 22% | 22% | 21% | 22% | 22% | 23% | 24% | 25% |
| Other Income + | -15 | 0 | 0 | 1 | -7 | 0 | 0 | 1 | 1 | 0 | 1 | -0 | 1 |
| Interest | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 2 | 3 |
| Depreciation | 4 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Profit before tax | -10 | 7 | 8 | 10 | 6 | 11 | 13 | 11 | 19 | 17 | 18 | 22 | 32 |
| Tax % | -24% | 25% | 24% | 21% | 29% | 25% | 33% | 25% | 24% | 30% | 23% | 28% | 20% |
| Net Profit + | -7 | 5 | 6 | 8 | 4 | 8 | 8 | 9 | 14 | 12 | 14 | 16 | 25 |
| EPS in Rs | -7.11 | 5.22 | 6.01 | 7.41 | 4.20 | 8.06 | 8.16 | 8.22 | 13.96 | 11.50 | 13.61 | 15.43 | 24.38 |
Financials of Kwality Pharmaceuticals Ltd
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 52 | 74 | 98 | 137 | 166 | 139 | 262 | 456 | 251 | 307 | 370 | 503 |
| Expenses + | 49 | 69 | 89 | 126 | 150 | 125 | 233 | 285 | 190 | 241 | 290 | 385 |
| Operating Profit | 3 | 5 | 9 | 12 | 16 | 14 | 29 | 172 | 61 | 66 | 80 | 118 |
| OPM % | 6% | 7% | 9% | 8% | 9% | 10% | 11% | 38% | 24% | 22% | 22% | 24% |
| Other Income + | 0 | -0 | 1 | 1 | 1 | 4 | 2 | 4 | -14 | -5 | 2 | 2 |
| Interest | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 7 | 10 | 10 | 11 |
| Depreciation | 1 | 2 | 3 | 3 | 3 | 4 | 6 | 11 | 15 | 20 | 18 | 20 |
| Profit before tax | 1 | 2 | 6 | 7 | 11 | 11 | 21 | 162 | 26 | 31 | 54 | 89 |
| Tax % | 41% | 48% | 42% | 39% | 31% | 25% | 30% | 26% | 25% | 24% | 26% | 25% |
| Net Profit + | 1 | 1 | 3 | 4 | 8 | 8 | 15 | 120 | 19 | 24 | 40 | 67 |
| EPS in Rs | 0.92 | 1.55 | 3.23 | 4.39 | 7.28 | 8.02 | 14.60 | 115.64 | 18.67 | 22.94 | 38.41 | 64.91 |
| Dividend Payout % | -0% | -0% | 9% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
Financials of Kwality Pharmaceuticals Ltd
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 5 | 5 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 15 | 17 | 20 | 19 | 27 | 36 | 51 | 171 | 190 | 214 | 254 | 321 |
| Borrowings + | 8 | 13 | 19 | 26 | 29 | 35 | 41 | 54 | 90 | 98 | 112 | 130 |
| Other Liabilities + | 10 | 17 | 26 | 40 | 39 | 52 | 64 | 105 | 70 | 72 | 71 | 130 |
| Total Liabilities | 37 | 51 | 71 | 96 | 105 | 133 | 166 | 341 | 361 | 394 | 447 | 592 |
| Fixed Assets + | 13 | 13 | 17 | 20 | 29 | 43 | 57 | 92 | 120 | 139 | 146 | 156 |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | 3 | 12 | 14 | -0 | -0 | 17 |
| Investments | 1 | 2 | 4 | 5 | 5 | 4 | 5 | -0 | -0 | -0 | -0 | -0 |
| Other Assets + | 24 | 37 | 50 | 70 | 71 | 86 | 102 | 237 | 226 | 255 | 302 | 420 |
| Total Assets | 37 | 51 | 71 | 96 | 105 | 133 | 166 | 341 | 361 | 394 | 447 | 592 |
Financials of Kwality Pharmaceuticals Ltd
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 1 | -3 | 4 | -1 | 14 | 6 | 27 | 61 | 41 | 43 | 53 | 17 |
| Cash from Investing Activity + | -1 | -2 | -7 | -6 | -12 | -18 | -23 | -63 | -48 | -26 | -29 | -35 |
| Cash from Financing Activity + | 1 | 6 | 5 | 5 | -2 | 12 | 1 | 6 | 1 | -17 | -14 | 7 |
| Net Cash Flow | 1 | 0 | 2 | -1 | -0 | 0 | 4 | 3 | -6 | -1 | 10 | -11 |
| Free Cash Flow | -0 | -5 | -2 | -7 | 2 | -12 | 3 | 5 | -4 | 17 | 28 | -29 |
| CFO/OP | 51% | -30% | 76% | 21% | 108% | 62% | 115% | 59% | 78% | 67% | 85% | 32% |
Financials of Kwality Pharmaceuticals Ltd
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 63 | 89 | 84 | 98 | 84 | 79 | 50 | 55 | 104 | 136 | 152 | 203 |
| Inventory Days | 61 | 67 | 71 | 54 | 34 | 94 | 38 | 97 | 310 | 187 | 167 | 111 |
| Days Payable | 40 | 63 | 65 | 80 | 52 | 96 | 58 | 63 | 117 | 106 | 112 | 144 |
| Cash Conversion Cycle | 85 | 93 | 90 | 73 | 67 | 77 | 30 | 90 | 297 | 217 | 208 | 170 |
| Working Capital Days | 35 | 41 | 20 | 18 | 20 | 43 | 24 | 60 | 118 | 101 | 98 | 128 |
| ROCE % | 9% | 13% | 19% | 19% | 22% | 18% | 26% | 98% | 19% | 16% | 18% | 24% |